KFSHRC Celebrates Landmark Contributions at 2024 NYC C3 Summit Davos of Healthcare
September 18, 2024 06:00 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Celebrates Landmark Contributions at 2024 NYC C3 Summit Davos of Healthcare
Canadian Scientist Franco Cavaleri Expands Biomedical Research into Cancer Studies through International Collaboration with Indian University
September 17, 2024 08:25 ET
|
Biologic Pharmamedical Inc.
Franco Cavaleri expands cancer research with India, offering post-doc opportunities, advancing biomedical science & fostering global healthcare innovation.
KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations
September 16, 2024 15:06 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations
KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions
September 15, 2024 07:05 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions
KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program
September 14, 2024 07:11 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program
KFSHRC Pioneering Ethical Innovation in Global Healthcare
September 13, 2024 07:42 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Pioneering Ethical Innovation in Global Healthcare
MetasTx Welcomes Esteemed Cancer Scientist Dr. Jonathan Chernoff to the Board of Managers
September 13, 2024 07:13 ET
|
MetasTx LLC
Dr. Chernoff’s decision to join the Board of Managers reflects his strong belief in MetasTx’s science and strategic direction.
Harvey Homan to Highlight MetasTx’s Game-Changing Approach to Cancer Treatment at PA Life Science Futures
September 12, 2024 06:58 ET
|
MetasTx LLC
MetasTx aims to revolutionize cancer treatment by targeting p21-activated kinase (PAK-1), a critical driver of metastasis in solid tumors.
Le PIONeeR Project présentera pour la première fois les résultats de son étude clinique de phase Ib/IIa lors de l’ESMO 2024
September 12, 2024 04:21 ET
|
The PIONeeR Project
Le PIONeeR Project présentera pour la première fois les résultats de son étude clinique de phase Ib/IIa lors de l’ESMO 2024 Le symposium présidentiel "Eyes to the future" sera l'occasion de présenter...
The PIONeeR Project to Present Late-Breaking Results from its Phase Ib/IIa umbrella study at the ESMO Congress 2024
September 12, 2024 04:21 ET
|
The PIONeeR Project
The PIONeeR Project to Present Late-Breaking Results from its Phase Ib/IIa umbrella study at the ESMO Congress 2024 The Presidential Symposium "Eyes to the future" will feature the first-ever...